Showing posts with label communication. Show all posts
Showing posts with label communication. Show all posts

Monday, March 22, 2021

2021 SGO Virtual Annual Meeting - Friday March 19th Highlights

I was happy to be able to attend the virtual SGO Annual Meeting. The meeting started on Friday, March 19 with sessions during the day and evenings over the weekend. The meeting continues with evening sessions through Thursday March 25th.  Interacting with presenters and others in the chat feature of the meeting platform was exceptionally good and helpful.

 In real time, I shared information on Twitter( @womenofteal) about the sessions I attended using the #gyncsm and #SGOmtg hashtags. Below are some tweets of Fridays sessions I found most interesting.

Friday

Nutritional Supplements 

Patient physician conversations

 PARP  inhibitors 

 

ARIEL 4  Rucaparib vs chemo

KEYNOTE 146  Pembrolizumab - Lenvatinib

Additional information may be found in the ASCO Post Article https://ascopost.com/news/march-2021/pembrolizumablenvatinib-may-improve-survival-in-advanced-endometrial-cancer/?utm_source=TAP%2DEN%2D032021&utm_medium=email&utm_term=51c356fa5771cf054b74a66e437b4089

Secondary Cytoreductive Surgery

Endometrial Cancer

Equity in Gyn Cancers

ACA and insurance


Here was a fun activity on the meeting platform - puzzle time! How I wish we were actually in Seattle

 

 

 

Dee

Every Day is a Blessing!

Posted by at No comments:
Labels: , , , , , , , , ,

Tuesday, June 30, 2020

iCARE -improving Communication about cancer Risk gEnes Project

Today I am sharing information about a new project at Rutgers Cancer Institute of NJ  to help understand how patients with BRCA mutations or Lynch Syndrome share their test results with family members.Check out the information below to find out how you can participate.


 


Many more patients are having genetic testing and it is important to provide information and tips on how to speak to family members about your results. 

Dee
Every Day is a Blessing ! 
Posted by at No comments:
Labels: , , , ,

Thursday, June 6, 2019

Education Sessions related to Communication at #ASCO19

I chose to attend two education sessions that dealt with communication. One Professional Development education session on Friday titled Tweets Chats and Posts: Using Social Media to Transcend Boundaries and Create Opportunities for Patients and the other a Pediatric Education session on Monday titled Navigating a New Cancer Diagnosis : Guiding Communication and Education. Below are some tweets and comments on each session

5/31/2019 Tweets Chats and Posts: Using Social Media to Transcend Boundaries and Create Opportunities for Patients 

Dr Subbiah, A Big World Made Small Using Social Media to Optimize Patient Care
I have followed Dr Subbiah on Twitter for a few years now so it was very nice to meet her in person.Dr Subbiah spoke on how to use Social Media effectively.




Dr Meisel, Using Social Media to Improve Clinical Trial Access and Opportunities
Dr Meisel mentioned how some health care providers may see social media as one more thing to do in their already busy day but went on to show the benefits of participating in social media such as recruiting for clinical trials. 
Dr Hamilton, The Metastatic Breast Cancer Project

 Dr Knoll, The Patient Perspective : Improving Patient Engagement in Clinical trials

6/3/2019 Navigating a New Cancer Diagnosis : Guiding Communication and Education

Dr Dobrozi Multidisciplinary Communication and Education Milestones Following a Cancer Diagnosis
Dr Mack Communication a New Cancer Diagnosis : From the Lense of the Patient and Caregiver


Dr Rosenberg Novel Approaches to Enhance the Educational Process and IMprove Patient Engagement

Some of the best advice to health care providers I heard at ASCO. 

Dee
Every Day is a Blessing!
Posted by at No comments:
Labels: , , , , , ,

Monday, June 4, 2018

#ASCO18 Twitter Highlights June 3, 2018

What do you do on a windy, cloudy, raining Sunday in NJ?
Follow tweets from the ASCO of course.

My Twitter news stream was filled with comments on these two non-gyn cancer studies.

Breast Cancer -
The Adjuvant Chemo and 21 Gene Expression Assay study reported at ASCO by Dr J Sparano may be found in this NJEM article https://www.nejm.org/doi/10.1056/NEJMoa1804710.
"Investigators “found that gene tests on tumor samples were able to identify women who could safely skip chemotherapy and take only a drug that blocks the hormone estrogen or stops the body from making it.” From the ASCO Cancer in the News e-mail  .

Lung Cancer - Keytruda Study (Pembroluzimab)
Keytruda "boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows. Keytruda (pembrolizumab) extended life four to eight months longer than chemotherapy in lung cancer patients whose immune systems had been duped by their cancer cells.
"This trial shows that pembrolizumab used alone improves survival as opposed to chemotherapy," said lead researcher Dr. Gilberto Lopes, a medical oncologist with the Sylvester Comprehensive Cancer Center at the University of Miami Health System." From HealthDay / ASCO Cancer in the News e-mail.
https://consumer.healthday.com/cancer-information-5/lung-cancer-news-100/cancer-drug-keytruda-a-new-weapon-against-advanced-lung-tumors-734492.html


Now on to the gyn Tweets/ Studies.
OVARIAN CANCER :

Keynote - niraparib and pembrolizumab
(Median duration response rate of 9.3 months)
 

Vaccine Trial


Genetic Testing

HPV / Cervical Cancer

Immune environment
Trial Design


 Communication

Cancer Prevention

Will check into the #gyncsm and #ASCO18 tweet streams a few times today to catch more news from the meeting. If you are there feel free to use those hashtags or tag me @womenofteal in your posts.

Dee
Every Day is a Blessing!
Posted by at No comments:
Labels: , , , , , , , , ,
Subscribe to: Comments (Atom)